Logo of Jana Medical Co.
Qualified investors started today, Nov. 6, subscribing to 642,500 shares of Jana Medical Co. on the Nomu-Parallel Market at SAR 40-44 apiece.
The shares on offer represent 25% of the company's pre-IPO capital of SAR 25.7 million, which is divided into 2.57 million shares, and 20% of the post-IPO capital of SAR 32.12 million, which will be divided into 3.21 million shares at SAR 10 par value each.
The subscription period will run for nine days until Nov. 14.
The IPO of Jana Medical on Nomu today brings the total number of listings on the parallel market to 22 this year, following the cancellation of Al-Hokail Academy Specialized Digital Polyclinics Co.’s offering and the postponement of Kinan International for Real Estate Development Co.’s listing.
In June 2024, the Capital Market Authority (CMA) approved the company’s request to register and float its shares on Nomu.
The subscription is limited to certain categories of investors, including capital market institutions authorized to act on their own accounts. This is in addition to clients of capital market institutions authorized to carry out management operations, provided they are appointed under terms that enable them to take decisions related to accepting participation in the share offering and investment in Nomu on behalf of clients without prior consent.
The categories include the Saudi government, any government or international entity approved by the CMA, the Saudi market, any other financial market recognized by the CMA, or the Securities Depository Center Co. (Edaa).
They also include companies owned by the government, directly or through a portfolio managed by a person authorized to practice management operations. This is in addition to investment funds, companies, and funds established in the GCC countries.
Additionally, the qualified investors include any legal person entitled to open investment accounts inside the Kingdom and with Edaa, as well as natural persons allowed to open investment accounts inside the Kingdom and with Edaa, provided they fulfill certain criteria, including the below:
They should have executed transactions in the capital markets worth a minimum of SAR 40 million and at least 10 deals in each quarter during the past 12 months.
Natural persons should also have a net asset value of at least SAR 5 million and be working or have worked for at least three years in the financial sector.
They should hold a CMA-approved certificate in securities dealing and a professional certificate in the field of securities business, approved by an internationally recognized body.
The list of qualified investors includes also any other persons as defined by the CMA.
Company Profile
Established in 2014 in Riyadh, Jana Medical specializes in importing and supplying medical equipment to public and private hospitals across the Kingdom. The company also owns several medical agencies.
Company Profile |
|
Company |
Jana Medical Co. |
Market |
Nomu Parallel Market |
Core Activities |
Importing and supplying medical devices, equipment, and supplies |
Pre-IPO Capital |
SAR 25.7 mln |
Number of shares |
2.57 mln shares |
Post-IPO Capital |
SAR 32.13 mln |
Number of shares after IPO |
3.21 mln |
Share Par Value |
SAR 10/share |
Company Shareholders |
||||
Shareholders |
Before IPO |
After IPO |
||
Number of Shares ('000) |
Ownership (%) |
Number of Shares ('000) |
Ownership (%) |
|
Jana Investment Holding Co. |
412.7 |
16.06% |
412.7 |
12.85% |
Eid Sultan Alotaibi |
360.3 |
14.02% |
360.3 |
11.21% |
Meteb Sultan Alotaibi |
8.9 |
0.35% |
8.9 |
0.28% |
Other shareholders owning less than 5% (7 shareholders) |
238.9 |
9.29% |
238.9 |
7.44% |
The public owning less than 5% (814 shareholders) |
1549.2 |
60.28% |
1549.2 |
48.22% |
The public (Qualified investors) |
-- |
-- |
642.5 |
20.00% |
Total |
2570 |
100% |
3212.5 |
100% |
IPO Summary |
|
Issue Percentage |
25% of pre-IPO capital 20% of post-IPO capital |
Offered shares |
642,500 shares |
IPO Minimum Limit |
10 shares |
IPO Maximum Limit |
157,400 shares |
Offer period |
Nov. 6-14, 2024 |
Final Allocation |
Nov. 19, 2024 |
Surplus Refund (if any) |
Nov. 24, 2024 |
Additional Information |
|
Financial Advisor |
Afaq Capital |
Lead Manager |
Musharaka Capital |
Receiving Entities |
Alistithmar Capital, Alinma Investment, SNB Capital, AlJazira Capital, Riyad Capital, ANB Capital, Albilad Capital, Al Rajhi Capital, Derayah Financial, Saudi Fransi Capital, SAB Invest, Alkhabeer Capital, Yaqeen Capital |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}